DOI:
10.1055/s-00029028
Journal of Pediatric Infectious Diseases
LinksClose Window
References
Cruz AT, Starke JR.
Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children.
Int J Tuberc Lung Dis 2014;
18 (09) 1057-1061
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.